Clinical Trials Browser

Unknown × Nivolumab × Other hematologic neoplasm × Clear all

NCT03825367 2022-10-12

Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT03146468 2021-09-23

NIVALLO

Phase 2 Unknown

Other hematologic neoplasm

Hematologic Neoplasms